NEW YORK (Reuters Health) – Dabigatran (Pradaxa, Boehringer Ingelheim) is as effective as warfarin in preventing stroke and systemic embolism after cardioversion in patients with nonvalvular atrial fibrillation,…
NEW YORK (Reuters Health) – In patients with chronic stable heart failure (HF) due to nonischemic dilated cardiomyopathy, a year’s treatment with n-3 polyunsaturated fatty acids (n-3 PUFAs)…
NEW YORK (Reuters Health) – Anticoagulation with low-molecular-weight heparin (LMWH) dalteparin following heart valve surgery leads to fewer adverse events than does unfractionated heparin, Canadian researchers report in…
Rosuvastatin should be considered for HIV-positive people with dyslipidemia — and guidelines should be updated to reflect that, suggests a new study. Although guidelines from the Infectious Diseases…
NEW YORK (Reuters Health) – In patients with atrial fibrillation, strict heart rate control provides no advantage over more lenient control, according to a focused update of the…
NEW YORK (Reuters Health) – Intravascular ultrasound guidance (IVUS) in patients treated with drug-eluting stent for bifurcation lesions, may improve long-term clinical outcomes, Korean researchers report in the…
NEW YORK (Reuters Health) – During transradial percutaneous coronary angiography, access through the left arm requires less fluoroscopy time and radiation dose than access through the right arm,…
NEW YORK (Reuters Health) – Spironolactone use is associated with improved long-term survival in patients with systolic heart failure, researchers from Japan report in the December American Heart…
NEW YORK (Reuters Health) – Compared to bare metal stent implantation, patients with acute myocardial infarction and failed thrombolysis who undergo percutaneous coronary intervention (PCI), do no better…
NEW YORK (Reuters Health) – Standard echocardiography will confirm or exclude a patent foramen ovale (PFO) in most children, without the need for transesophageal echocardiography (TEE), clinicians from…